CRISPR-CAS9 GENE EDITING THERAPEUTICS: FROM FIRST APPROVAL TO EXPANDING CLINICAL PIPELINE. (2026). Global Conference on Medical and Health Sciences, 1(9), 29-36. http://econferencia.com/index.php/5/article/view/1409